QHM-2025-4188 Intrahealth Limited (Integrated Diabetes and Diabetic Foot Screening)

The NHS North East and North Cumbria Integrated Care Board has announced the award of a contract titled "QHM-2025-4188 Intrahealth Limited (Integrated Diabetes and Diabetic Foot Screening)," valued at £72,096. The contract was awarded using a Direct Award process under the Health Care Services Provider Selection Regime Regulations 2023, outside the scope of The Procurement Act 2023. This services procurement process, classified under the CPV code 85121200 for Medical specialist services, includes the provision of integrated diabetes and diabetic foot screening services in the UKC region.

The contract commenced on 1 April 2025 and is set to conclude on 31 March 2026, having gone through amendment confirmations and procedural assurances without identifying conflicts of interest. This procurement presents business growth opportunities for healthcare providers, particularly those capable of offering specialised medical services in diabetes and foot care. Businesses that are well-positioned to benefit include those with expertise in healthcare service delivery, especially firms already operating within the UK's healthcare system or with prior recipient experience under the Provider Selection Regime.

The limited procurement method, which involves no prior advertisement and a focus on existing service provision, suggests that entities with a robust track record and the capacity to fulfil the outlined service requirements would be well-suited to compete for similar contracts in the future.